Samuel Pope, MD

Division of Pulmonary and Critical Care Medicine

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-1227) Population Pharmacokinetics (PK) of Cefiderocol (FDC) during Acute Pulmonary Exacerbations (APE) in Adult Persons with Cystic Fibrosis (CF)
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT